2013
DOI: 10.1111/iji.12099
|View full text |Cite
|
Sign up to set email alerts
|

Nomenclature for factors of the HLA system, update August 2013

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Marsh, ), names will be assigned to new sequences as they are identified. The three novel alleles were listed in the updated WHO Nomenclature Report (Marsh, ) and were made available in 3.14.0 release version of IMGT/HLA database.…”
Section: Resultsmentioning
confidence: 99%
“…This follows the agreed policy that, subject to the conditions stated in the most recent Nomenclature Report (Marsh, ), names will be assigned to new sequences as they are identified. The three novel alleles were listed in the updated WHO Nomenclature Report (Marsh, ) and were made available in 3.14.0 release version of IMGT/HLA database.…”
Section: Resultsmentioning
confidence: 99%
“…This new A*03 allele was subsequently named HLA‐A*03:162N in October 2012 (cell identification: UKNEQAS 4A2 09/12, accession number: HE995437) and later confirmed in the same donor by another laboratory in August 2013 (cell identification: 64362, accession number: HG417079) .…”
mentioning
confidence: 99%
“…The name C*12:109 has been officially assigned by the World Health Organization (WHO) Nomenclature Committee in August 2013 . The confirmatory sequence of C*12:109 (submission number HWS10057237) was submitted to the IPD‐IMGT/HLA Database in November 2019. This follows the agreed policy that, subject to conditions stated in the most recent Nomenclature Report, names will be assigned to new sequences as they are identified.…”
mentioning
confidence: 99%